Research Correspondence

DOI: 10.4244/EIJ-D-24-00902

Long-term predictors of target vessel failure after intracoronary lithotripsy: 12-month results from the France LILI registry

Benjamin Honton1, MD; Hakim Benamer2, MD; Benoit Lattuca3, MD, PhD; Thibault Lhermusier4, MD; Nicolas Amabile2,5, MD, PhD; Frederic Marco6, MD; Janusz Lipiecki7, MD; Ashok Tirouvanziam8, MD; Julien Jeanneteau9, MD; Eric Van Belle10, MD, PhD; Alexandre Canville11, MD; Grégoire Rangé12, MD; Matthieu Périer13, MD; Jacques Monsegu14, MD; Thomas Cuisset15, MD, PhD; Géraud Souteyrand16, MD, PhD; Gonzalo Quaino17, MD; Marine Quillot18, MD; Gael Bouchou19, MD; Fabrice Leroy20, MD; Christophe Saint Etienne21, MD; Sebastien Levesque22, MD; Antoine Gommeaux23, MD; Antoine Gerbay24, MD; Benjamin Seguy25, MD; Benjamin Fialon26, MD; Julien Adjedj27, MD; Louis-Marie Desroche28, MD; Luc Maillard29, MD, PhD; Nicolas Lhoest30, MD; Olivier Darremont31, MD; Martine Gilard32, MD, PhD; Edouardo Aptecar33, MD; Pascal Motreff16, MD, PhD; Vincent Bataille34, PhD; Philippe Commeau35, MD; Guillaume Cayla3, MD, PhD

Coronary artery calcification is a frequent challenge in percutaneous coronary intervention (PCI), often associated with suboptimal procedural outcomes due to difficulties in lesion crossing, stent expansion, and a poor long-term clinical prognosis1. Intravascular lithotripsy (IVL) offers a promising solution using acoustic waves to modify calcified lesions and increase vessel compliance before stenting. However, despite the growing adoption of IVL, particularly in patients with severe calcifications, real-world long-term data remain scarce2. The France LILI registry was established to assess the long-term safety and efficacy of IVL in a large cohort of unselected patients treated in routine clinical practice.

France LILI (ClinicalTrials.gov: NCT05113407) is a prospective, multicentre, national registry that included 500 patients from 34 centres across France, all of whom underwent PCI with adjunctive IVL using the Shockwave C2 coronary lithotripsy system (Shockwave Medical). The primary endpoint was target vessel failure (TVF) − a composite of cardiac death, all myocardial infarction (MI), and ischaemia-driven target vessel revascularisation (ID-TVR) − assessed at 12 months. Secondary endpoints included procedural success, device success, and identification of factors associated with TVF. All clinical...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 15
Aug 4, 2025
Volume 21 Number 15
View full issue


Key metrics

Suggested by Cory

Expert review

10.4244/EIJ-D-18-01056 Oct 18, 2019
Intravascular lithotripsy for calcific coronary and peripheral artery stenoses
Dini C et al
free

Clinical research

10.4244/EIJ-D-21-00545 Sep 20, 2022
Coronary lithotripsy for the treatment of underexpanded stents: the international; multicentre CRUNCH registry
Tovar Forero M et al
free

Short report

10.4244/EIJ-D-19-01052 May 20, 2020
Intravascular lithotripsy for lesion preparation in patients with calcific distal left main disease
Cosgrove C et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00175 Dec 6, 2019
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention
Azzalini L et al
free

Image – Interventional flashlight

10.4244/EIJ-D-18-00780 May 20, 2019
Intravascular lithotripsy to treat a severely underexpanded coronary stent
Watkins S et al
free

Translational research

10.4244/EIJ-D-23-00487 Dec 18, 2023
Intravascular laser lithotripsy for calcium fracture in human coronary arteries
Gruslova AB et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00268 Jul 17, 2020
Intravascular lithotripsy for recurrent restenosis caused by severe calcific neoatherosclerosis
Salazar C et al
free
Trending articles
94.75

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.55

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved